| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/28/2009 | EP2018368A1 Malonamide derivatives as gamma secretase inhibitors |
| 01/28/2009 | EP2018364A1 Therapeutic fluoroethyl ureas |
| 01/28/2009 | EP2018211A2 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 01/28/2009 | EP2018178A2 Administration of agonist-antagonist in opioid-dependent patients |
| 01/28/2009 | EP2018150A1 Pharmaceutical composition having reduced abuse potential |
| 01/28/2009 | EP1446400B1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 01/28/2009 | EP1418910B1 Methods for inhibiting or reversing tau filament formation polymerization |
| 01/28/2009 | EP1315701B1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | CN101356172A 激酶抑制剂 Kinase inhibitors |
| 01/28/2009 | CN101356169A 吡嗪衍生物 Pyrazine derivatives |
| 01/28/2009 | CN101356167A Chroman compounds as 5-HT1B antagon |
| 01/28/2009 | CN101356163A Sulfanyl substituted phenyl methanones as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 01/28/2009 | CN101355953A Promoter for recovery from anesthesia |
| 01/28/2009 | CN101355946A Compounds for modulating TRPV3 function |
| 01/28/2009 | CN101355940A In vivo or in vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 01/28/2009 | CN101353664A siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof |
| 01/28/2009 | CN101353646A Telomerase immortalized human fetal forebrain neural precursor cell line and construction method thereof |
| 01/28/2009 | CN101352568A New use of specific sodium channel modulation preparation BmK IT2 |
| 01/28/2009 | CN101352567A Composition for treating ache |
| 01/28/2009 | CN101352564A Novel medical use of pills for resuscitation and reconstruction |
| 01/28/2009 | CN101352552A Capsules for promoting children's intelligence, growth and development |
| 01/28/2009 | CN101352543A Walnut tuckahoe oral liquid and method for producing the same |
| 01/28/2009 | CN101352533A Chinese patent medicine for treating psychosis and preparation method thereof |
| 01/28/2009 | CN101352530A Medicine for treating epilepsy |
| 01/28/2009 | CN101352529A Chinese medicine preparation for quickly treating headache |
| 01/28/2009 | CN101352509A Velvet deerhorn liquor for delaying apolexis and improving sleep and preparation method thereof |
| 01/28/2009 | CN101352502A Plaster for curing facial paralysis and method of preparing the same |
| 01/28/2009 | CN101352491A Foot plaster medicament for treating trigeminal neuralgia |
| 01/28/2009 | CN101352473A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352472A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352471A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352470A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352469A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352422A Tetrodotoxin lyophilized powder formulation for injection and preparation method thereof |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN101352233A Health products for preventing senile dementia and improving memory |
| 01/28/2009 | CN101352213A Five-color total nutrient rice and production method |
| 01/28/2009 | CN100455595C Protein of interreaction with karyomitosis primary activator protein kinase p38 and its coding gene and application |
| 01/28/2009 | CN100455581C Imidazopyridine derivatives as melanocortin receptor agonists. |
| 01/28/2009 | CN100455572C Dibenzo(b,f)azepine derivatives |
| 01/28/2009 | CN100455564C Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 01/28/2009 | CN100455560C Medicine precursor containing long chain fatty acyl group substituted venlafaxine and its prepn and use |
| 01/28/2009 | CN100455303C Ultrasonic extraction technology of xiasangju |
| 01/28/2009 | CN100455301C Therapeutical use of sophora flavescens or sophora subprostrated extracts |
| 01/28/2009 | CN100455297C Quality detecting method for Radix-Acanthopanacis-leaf total flavone extract frozen dry powder injecta |
| 01/28/2009 | CN100455215C Sobering pear juice beverage and its prepn. method |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482362 Substituted-4-quinolones |
| 01/27/2009 | US7482339 Cannabinoid receptor agonists; antipruritic agents, analgesics, bronchodilator agents |
| 01/27/2009 | US7482338 Non-amide nonanes |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482138 PAK5-related compositions and methods |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/27/2009 | CA2346644C Method for preventing xenograft transplant rejection using photodynamic therapy |
| 01/27/2009 | CA2338066C Treatment of dyskinesia |
| 01/27/2009 | CA2334355C Prostaglandin derivatives |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2265198C Method of producing a nicotine medicament and a medicament made by the method |
| 01/27/2009 | CA2264028C A stable ointment containing acetyl salicylic acid |
| 01/27/2009 | CA2196339C Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 01/22/2009 | WO2009012425A2 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 01/22/2009 | WO2009012252A1 Aminoalkylazole derivatives as histamine-3 antagonists |
| 01/22/2009 | WO2009012242A2 Sodium channel inhibitors |
| 01/22/2009 | WO2009012205A1 Inhibitors of beta amyloid production |
| 01/22/2009 | WO2009012082A1 Methods for treating anxiety |
| 01/22/2009 | WO2009011901A2 Methods for promoting wakefulness |
| 01/22/2009 | WO2009011870A1 Reduction of beta-amyloid levels by treatment with the small molecule differentiation-inducing factor |
| 01/22/2009 | WO2009011561A1 Pharmaceutical composition combining lamotrigine and clonazepam, and use thereof for treating convulsive disorders and epileptic syndromes |
| 01/22/2009 | WO2009011560A1 Pharmaceutical composition combining risperidone and donepezil, and use thereof for treating psychotic disorders such as schizophrenia and dimentias such as alzheimer's disease |
| 01/22/2009 | WO2009011412A2 Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain |
| 01/22/2009 | WO2009011411A1 Ampa receptor antagonists and zonisamide for neuropathic pain |
| 01/22/2009 | WO2009011410A1 Ampa receptor antagonists and aldose reductase inhibitors for neuropathic pain |
| 01/22/2009 | WO2009011336A1 Quinoline compounds |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009010988A1 An improved, industrially viable process for the preparation of high purity paliperidone |
| 01/22/2009 | WO2009010968A2 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | WO2009010784A1 New compounds 955 |
| 01/22/2009 | WO2009010560A1 Pyrazole derivatives and use thereof as inhibitors of stearoyl-coa desaturase |
| 01/22/2009 | WO2009010454A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/22/2009 | WO2009010299A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/22/2009 | WO2009010107A1 Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis |
| 01/22/2009 | WO2009010045A1 Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains |
| 01/22/2009 | WO2009009829A1 Method for reducing intracranial pressure |
| 01/22/2009 | WO2008148023A3 Compositions and methods for treating neurological disorders |
| 01/22/2009 | WO2008145842A3 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/22/2009 | WO2008125600A3 Pyrazole derivatives as p2x7 modulators |
| 01/22/2009 | WO2008122723A3 Use of poly-unsaturated fatty acids and flavonoids as active ingredients in a composition for preventing and/or treating migraines |